Antitumour necrosis factor α treatment reduces retinol-binding protein 4 serum levels in non-diabetic ankylosing spondylitis patients. Issue 5 (9th December 2013) - Genre, Fernanda; López-Mejías, Raquel; Miranda-Filloy, José A; Ubilla, Begoña; Carnero-López, Beatriz; Gómez-Acebo, Inés; Blanco, Ricardo; Ochoa, Rodrigo; Rueda-Gotor, Javier; Pina, Trinitario; González-Juanatey, Carlos; Llorca, Javier; et al.